Amtrust Financial Services’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-75,000
Closed -$752K 54
2021
Q2
$752K Hold
75,000
0.55% 26
2021
Q1
$754K Hold
75,000
0.48% 37
2020
Q4
$788K Buy
+75,000
New +$782K 0.38% 39

Other funds holding MTACU

Amtrust Financial Services's MTACU Position: Q3 2021 in Review

Amtrust Financial Services sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2021, closing a stake of 75,000 shares — an estimated $752K sold.

Amtrust Financial Services first reported a position in MTACU in Q4 2020 and held it in 3 quarters. The position peaked at $788K in Q4 2020. 20 funds tracked by Wall St. Rank hold MTACU as of Q3 2021.

  • Amtrust Financial Services reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
  • Amtrust Financial Services sold 75,000 MedTech Acquisition Corporation Unit shares in Q3 2021, an estimated $752K.
  • Amtrust Financial Services first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 3 quarters.
  • Amtrust Financial Services's MedTech Acquisition Corporation Unit position peaked at $788K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2021.

Based on Amtrust Financial Services's 13F filing for Q3 2021, filed 12 Nov 2021.